Kroni̇k Hastalığı Olan Çocuğun İzlemi̇ ve Toplumda Bakımı

EnglishTürkçe

BÖLÜM


DOI :10.26650/B/CH32.2024.010.035   IUP :10.26650/B/CH32.2024.010.035    Tam Metin (PDF)

Epi̇lepsi̇si̇ Olan Çocuğun İzlemi̇ ve Toplumda Bakımı

Edibe Pembegül Yıldız, Meliha Mine Çalışkan

Epilepsi, çocukluk çağında en sık görülen kronik nörolojik hastalıktır. Yaşamın ilk yılında görülme sıklığı çocukluk ve ergenlik dönemine göre daha yüksektir. Tanıda önerilen adımlar nöbet tipinin, epilepsi tipinin (fokal, jeneralize, kombine jeneralize ve fokal, bilinmeyen) ve epilepsi sendromunun belirlenmesidir. Epilepsiyi sadece tekrarlayan nöbetlere yatkınlık durumu olarak değil, nöbetlerin bilişsel ve sosyal sonuçlarının toplamı olarak değerlendirip ele almak gerekir. Klinisyenlerin hem yeni tanı almış çocuklarda hem de tedavi sonrası düzenli takipleri olan çocuklarda olası nörolojik ve psikolojik komorbiditeleri taramaları ve değerlendirmeleri önerilir. Nöbetlerin başlangıç yaşı, uzun hastalık süresi, semptomatik neden, epileptik ensefalopati, yoğun elektroensefalogram (EEG) bulguları ve devam eden nöbet önleyici ilaçlar ile tedavisinin bilişsel prognozla ilişkili olduğu bildirilmiştir Ayrıca bu çocukların altta yatan nedenden veya tedavinin olumsuz etkilerinden kaynaklanabilecek sistemik sorunlarının farkında olup multidisipliner izlemleri sağlanmalıdır. Ebeveynler öğretmeni, okul hemşiresini, servis sürücüsünü, hatta çok yakın bazı arkadaşlarını çocuğun hastalığı ile ilgili mutlaka bilgilendirmelidirler. Çocukların izlemi bireyselleştirilmeli, fiziksel ve bilişsel etkilenimleri, kullanılan ilaçların özellikleri, özel gereksinim duydukları alanlar belirlenerek herhangi bir sosyal izolasyona yol açmadan takipleri yapılmalıdır. Aynı zamanda büyüme ve gelişme sürecinde olan bu çocukların beslenme, bağışıklama, sosyal hayat, fiziksel aktivite açısından izlemlerinin sağlıklı çocuklardan belirgin farklılıklarının olmadığı unutulmamalıdır. Bu yazıda epilepsi sorunu olan çocuklarda bilinen, birlikte görülen durumlar ve izlemleri sırasında dikkat edilecek hususlar gözden geçirilecektir


Anahtar Kelimeler: Epilepsi, aşı, davranış sorunları, anti-nöbet ilaç, prognoz
DOI :10.26650/B/CH32.2024.010.035   IUP :10.26650/B/CH32.2024.010.035    Tam Metin (PDF)

Follow-up and Community Care of the Child with Epilepsy

Edibe Pembegül Yıldız, Meliha Mine Çalışkan

Epilepsy is the most common chronic neurological disease in children. The incidence is higher in the first year of life than in childhood and adolescence. The recommended step in the diagnosis is identifying the seizure type, epilepsy type (focal, generalized, combined generalized, or focal, unknown), and epilepsy syndrome. Epilepsy is not only a predisposition for recurring seizures; it should be evaluated and managed as the total of the seizure’s cognitive and social consequences. Clinicians should screen and evaluate possible neurological and psychological comorbidities in children with epilepsy. The age of onset of seizures, long disease duration, symptomatic cause, epileptic encephalopathy, intense electroencephalogram findings, and ongoing antiseizure drug therapy have been associated with cognitive prognosis. In addition, these children should be made aware of any systemic problems that may occur due to the treatment’s etiology or side effects, and multidisciplinary follow-up should be provided. The teacher, school nurse, bus driver, and even some of the child’s close friends should be informed of the child’s condition. The follow-up of children should be tailored; their physical and cognitive effects, the characteristics of the drugs used, and the areas they require special attention should be monitored without causing social isolation. At the same time, it should be noted that the follow-up of growing and developing children is not significantly different from that of healthy children regarding nutrition, immunization, social life, and physical activity. In this section , known comorbid conditions in children with epilepsy and the points to be considered during their follow-up will be reviewed.


Anahtar Kelimeler: Anti-seizure medication, behavioral problems, epilepsy, prognosis, vaccination

Referanslar

  • 1. Wirrell E. Infantile, childhood, and adolescent epilepsies. Continuum (Minneap Minn). 2016; 22: 60-93. google scholar
  • 2. Berg AT, Nickels K, Wirrell EC, Geerts AT, Callenbach PM, Arts WF, et al. Mortality risks in new-onset childhood epilepsy. Pediatrics. 2013; 132: 124-131. google scholar
  • 3. Fisher RS, Cross JH, French JA, Higurashi N, Hirsch E, Jansen FE, et al. Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017; 58: 522-530. google scholar
  • 4. Wei SH, Lee WT. Comorbidity of childhood epilepsy. J Formos Med Assoc. 2015; 114: 1031-1038. google scholar
  • 5. M. Filippini, A. Boni, G. Dazzani, A. Guerra, G. Gobbi. Neuropsychological findings: myoclonic astatic epilepsy (MAE) and Lennox-Gastaut syndrome (LGS) Epilepsia. 2006; 47: 56-59. google scholar
  • 6. L.L. Bailet, W.R. Turk. The impact of childhood epilepsy on neurocognitive and behavioral performance: a prospective longitudinal study. Epilepsia. 2000; 41: 426-431. google scholar
  • 7. Berg AT, Langfitt JT, Testa FM, Levy SR, DiMario F, Westerveld M, et al. Global cognitive function in children with epilepsy: a community-based study. Epilepsia 2008; 49: 608-614. google scholar
  • 8. Fastenau PS, Johnson CS, Perkins SM, Byars AW, deGrauw TJ, Austin JK, et al. Neuropsychological status at seizure onset in children: risk factors for early cognitive deficits. Neurology 2009; 73: 526-534. google scholar
  • 9. Reilly CJ. Attention deficit hyperactivity disorder (ADHD) in childhood epilepsy. Res Dev Disabil 2011; 32: 883-893. google scholar
  • 10. Brikell I, Chen Q, Kuja-Halkola R, D’Onofrio BM, Wiggs KK, Lichtenstein P, et al. Medication treatment for attention-deficit/hyperactivity disorder and the risk of acute seizures in individuals with epilepsy. Epi-lepsia. 2019; 60: 284-293. google scholar
  • 11. Auvin S, Wirrell E, Donald KA, Berl M, Hartmann H, Valente KD, et al. Systematic review of the scree-ning, diagnosis, and management of ADHD in children with epilepsy. Consensus paper of the Task Force on Comorbidities of the ILAE Pediatric Commission. Epilepsia. 2018; 59: 1867-1880. google scholar
  • 12. AT. Berg, J.T. Langfitt, F.M. Testa, S.R. Levy, F. DiMario, M. Westerveld, et al. Global cognitive function in children with epilepsy: a community-based study Epilepsia. 2008; 49: 608-614. google scholar
  • 13. P.S. Fastenau, C.S. Johnson, S.M. Perkins, A.W. Byars, T.J. deGrauw, J.K. Austin, et al. Neuropsychological status at seizure onset in children: risk factors for early cognitive deficits. Neurology. 2009; 73: 526-534. google scholar
  • 14. H.C. Kang, B.L. Eun, C. Wu Lee, H. Ku Moon, J.S. Kim, D. Wook Kim, et al. The effects on cognitive function and behavioral problems of topiramate compared to carbamazepine as monotherapy for children with benign rolandic epilepsy. Epilepsia. 2007; 48: 1716-1723. google scholar
  • 15. Coppola G, Fortunato D, Auricchio G, Mainolfi C, Operto FF,Signoriello G, et al. Bone mineral density in children, adolescents, and young adults with epilepsy. Epilepsia 2009; 50: 2140-2146. google scholar
  • 16. A. Verrotti, F. Basciani, S. Morresi, G. Morgese, F. Chiarelli. Thyroid hormones in epileptic children rece-iving carbamazepine and valproic acid. Pediatr Neurol. 2001; 25: 43-46. google scholar
  • 17. Charlton R, Damase-Michel C, Hurault-Delarue C, Gini R, Loane M, Pierini A, et al. Did advice on the prescription of sodium valproate reduce prescriptions to women? An observational study in three European countries. Pharmacoepidemiol Drug Saf 2019; 28: 1519-1528. google scholar
  • 18. Ben-Menachem E, Ben-Menachem E. Weight issues for people with epilepsy review. Epilepsia 2007; 48: 42-45. google scholar
  • 19. KA. Top, P. Brna, L. Ye, B. Smith. Risk of seizures after immunization in children with epilepsy: a risk interval analysis. BMC Pediatr. 2018; 18: 134. google scholar
  • 20. K.A. Top, C.H. Righolt, S. Hawken, J. Donelle, G. Pabla, P. Brna, et al. Adverse events following immuni-zation among children with epilepsy: a self-controlled case series, Pediatr. Infect. Dis. J. 2020; 39: 454-459. google scholar
  • 21. M Goodman, S.H. Lamm, M.H. Bellman. Temporal relationship modeling: DTP or DT immunizations and infantile spasms. Vaccine. 1998; 16: 225-232. google scholar
  • 22. Verbeek NE, van der Maas NA, Sonsma AC, Ippel E, Vermeer-de Bondt PE, Hagebeuk E, et al. Effect of vaccinations on seizure risk and disease course in Dravet syndrome. Neurology, 2015; 85: 596-603. google scholar
  • 23. A. Brunklaus, R. Ellis, E. Reavey, G.H. Forbes, S.M. Zuberi. Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome. Brain. 2012; 135: 2329-2336. google scholar
  • 24. Craiu D, Rener Primec Z, Lagae L, Vigevano F, Trinka E, Specchio N, et al. Vaccination and childhood epilepsies. Eur J Paediatr Neurol. 2022; 36: 57-68. google scholar
  • 25. Perucca E. Clinically relevant drug interactions with antiepileptic drugs. Br J Clin Pharmacol. 2006; 61: 246-55. google scholar
  • 26. Patsalos PN, Perucca E. Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs. Lancet Neurol. 2003; 2: 473-81. google scholar
  • 27. Pisani F, Fazio A, Oteri G, Ruello C, Gitto C, Russo F, et al. Sodium valproate and valpromide: differential interactions with carbamazepine in epileptic patients. Epilepsia. 1986;27: 548-552. google scholar
  • 28. Borowicz-Reutt KK, Czuczwar SJ, Rusek M. Interactions of antiepileptic drugs with drugs approved for the treatment of indications other than epilepsy. Expert Rev Clin Pharmacol. 2020; 13: 1329-1345. google scholar
  • 29. Brna PM, Gordon KE, Woolridge E, Dooley JM, Wood E. Perceived need for restrictions on activity for children with epilepsy. Epilepsy Behav 2017; 73: 236-239. google scholar
  • 30. Tian N, Shaw EC, Zack M, Kobau R, Dykstra H, Covington TM. Cause-specific mortality among children and young adults with epilepsy: Results from the U.S. National Child Death Review Case Reporting System. Epilepsy Behav 2015; 45: 31-34. google scholar
  • 31. Reilly C, Atkinson P, Das KB, Chin RF, Aylett SE, Burch V, et al . Academic achievement in school-aged children with active epilepsy: a population-based study. Epilepsia 2014; 55: 1910-1917. google scholar
  • 32. Türkiye Çocuk Nörolojisi Derneği, Aileler için Epilepsi Rehberi, 2020. Erişim: chrome-extension://efaid-nbmnnnibpcajpcglclefindmkaj/http://cnd.org.tr/folders/file/aileleler_icin_epilepsi_rehberi_2020.pdf. Son erişim tarihi: 07.01.2023. google scholar


PAYLAŞ




İstanbul Üniversitesi Yayınları, uluslararası yayıncılık standartları ve etiğine uygun olarak, yüksek kalitede bilimsel dergi ve kitapların yayınlanmasıyla giderek artan bilimsel bilginin yayılmasına katkıda bulunmayı amaçlamaktadır. İstanbul Üniversitesi Yayınları açık erişimli, ticari olmayan, bilimsel yayıncılığı takip etmektedir.